The virus that causes COVID-19 acts as a pain reliever, suggests the findings of a new study that could offer “one possible explanation for the unrelenting spread” of the disease, researchers said. Researchers with the University of Arizona Health Sciences said SARS-CoV-2, the virus that causes COVID-19, may inadvertently function as a pain reliever, which “may explain why nearly half of all people who get COVID-19 experience few or no symptoms, even though they are able to spread the disease.

The $2.3 million National Institutes of Health grant will enable Dr. Alicia Allen to explore how women’s hormones influence postpartum opioid relapse and if they may be used as a preventative strategy.

An international research team has found further evidence that rare gene mutations can cause cerebral palsy, findings which could lead to earlier diagnosis and new treatments for this devastating movement disorder. Michael Kruer, a neurogeneticist at Phoenix Children’s Hospital and the University of Arizona College of Medicine – Phoenix, is senior author of the study.

President Trump is described as symptom-free, but experts question the significance of his antibody test results. Dr. Deepta Bhattacharya, an immunologist at the University of Arizona College of Medicine said the results shared by White House physician Dr. Sean P. Conley wouldn’t shed much light on Mr. Trump’s condition. “The way that it’s implied is that he’s made a normal immune response, but I don’t see how you would be able to tell the difference.”

Coronavirus could go on undetected for some people. As the President of America reportedly has 'no symptoms' after falling ill, scientists discover how the disease may dull the senses. In October 2020, researchers from the University of Arizona Health Sciences revealed coronavirus is capable of dulling pain pathways. The study is published in the journal Pain.

Skipping radiation and receiving less chemotherapy may become the new standard of care for some lymphoma patients, according to a recent collaborative study led by a Daniel Persky, MD, associate director for clinical investigations at the UArizona Cancer Center.

New research from the University of Arizona Health Sciences could explain why nearly half of all people who get coronavirus show few or no symptoms.

The Phoenix VA Health Care System Research Space will be an incubator for medical discovery, new technologies and clinical care on the Phoenix Biomedical Campus in downtown Phoenix in partnership with the University of Arizona College of Medicine – Phoenix.

University of Arizona Cancer Center researcher Dr. Daniel Persky led a study that found many patients with the most common type of non-Hodgkin’s lymphoma, diffuse large B-cell lymphoma (DLBCL), can safely skip radiation and receive fewer chemotherapy treatments.